NanoTYPE HLA – A New Era of HLA Typing

10/05/2022

Written by Libor Kolesár, PhD HLA tissue typing is like a constantly changing and evolving organism. During the era of SSP and SSOP methods, Sanger-based typing (SBT) was developed and quickly became the gold standard. SBT had several advantages over SNP-based methods (SSP and SSOP) as it was not...

EFI 2022

10/05/2022

EFI 2022 | Tolerance, Acceptance and Permissiveness After 2 long years, the opportunity to meet and greet is open again in the event of the 35th EFI Annual Meeting in Amsterdam. Our team is very excited to meet many people from the field again in person. We...

Renewed Omixon Monthly Newsletter

09/05/2022

We are thrilled to announce that Omixon’s monthly newsletter has been renewed. We keep continuously delivering fresh news of HLA research, genetics and immunogenetics to our readers, but we are going to wrap this info package into a new format. The revamped newsletter contains more visual elements and less...

New Business Partnership For Guiding Microchimerism to Transplant Diagnostics with DigitalTRACE™

07/04/2022

Omixon is pleased to announce that we have been entered a new strategic partnership of JETA Molecular BV., based in Utrecht, The Netherlands, effective as of April 2022. This partnership will combine Omixon’s expertise as an international provider of disruptive transplant diagnostics solutions with JETA Molecular latest technological solutions...

Let’s Get Together at ASHI 2021!

24/09/2021

Let’s Meet Live at ASHI Omixon Booth #211 We are excited to exhibit again at ASHI 2021 between 27th September – 1st October in Orlando, (Florida, US). Our colleagues cannot wait to meet, catch up, and share knowledge with the attendees. We have a couple of special news, activities and games with...